Hokkaido, Japan

Tatsuya Igarashi

This inventor holds 3 USPTO granted patents, plus 3 CIPO patents and 3 EPO patents. Top assignees: Hokkaido University, Mochida Pharmaceutical Co., Ltd.. Active years: 2013-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tatsuya Igarashi. Retrieved from https://idiyas.com/inventor/tatsuya-igarashi-3ylugos1

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 66.7

 


Average Co-Inventor Count = 8.2

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2013-2015

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Tatsuya Igarashi: Innovator in Cartilage Regeneration

Introduction

Tatsuya Igarashi is a notable inventor based in Hokkaido, Japan. He has made significant contributions to the field of cartilage regeneration, holding three patents that focus on innovative methods and compositions for treating cartilage diseases. His work aims to improve the quality of life for individuals suffering from cartilage-related issues.

Latest Patents

Igarashi's latest patents include a method for regenerating hyaline cartilage. This invention provides a composition for regenerating cartilage or treating cartilage diseases, which contains a monovalent metal salt of alginic acid. The endotoxin level of this composition has been lowered to an extent that does not substantially induce inflammation or fever. As a result, it is possible to provide a composition that enhances cartilage regenerative action and facilitates application to cartilage injury lesions. Additionally, this composition protects cartilage from mechanical irritation, inhibits degenerative changes caused by wear and inflammation, repairs cartilage injury lesions, and alleviates inflammation and pain in joint tissue.

Another significant patent by Igarashi is focused on compositions and methods for treating cartilage disease. Similar to his previous invention, this composition also contains a monovalent metal salt of alginic acid with a reduced endotoxin level. The benefits of this composition include improved cartilage regeneration and ease of application, along with protective effects against mechanical irritation and degenerative changes.

Career Highlights

Throughout his career, Tatsuya Igarashi has worked with prominent organizations, including Mochida Pharmaceutical Co., Ltd. and Hokkaido University. His experience in these institutions has allowed him to develop and refine his innovative approaches to cartilage treatment.

Collaborations

Igarashi has collaborated with notable colleagues such as Norimasa Iwasaki and Akio Minami. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Tatsuya Igarashi is a pioneering inventor whose work in cartilage regeneration has the potential to significantly impact the treatment of cartilage diseases. His innovative patents reflect a commitment to improving patient outcomes and advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…